Literature DB >> 15972173

Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.

Stein G Larsen1, Johan N Wiig, Karl-Erik Giercksky.   

Abstract

BACKGROUND: After multimodal treatment estimated 5-year survival of locally recurrent rectal cancer is about 25%. Hydronephrosis secondary to pelvic recurrence of colorectal cancer is a condition claimed to represent a contraindication to surgery due to a dismal prognosis.
METHODS: Prospective registration of 193 consecutive patients operated for pelvic recurrence in rectal or colon cancer from January 1991 until March 2002 at a tertiary referral hospital, 121 men and 72 women, median age 67 years, all given irradiation preoperatively. Twenty-three of 193 had hydronephrosis prior to preoperative irradiation for recurrent disease.
RESULTS: R-0 stage resection was obtained in 22% of patients with hydronephrosis and in 41% without. The median survival times in patients without metastasis were 27 and 32 months, respectively, and 5-year survival rates were 11% and 25%.
CONCLUSIONS: An aggressive surgical approach offers patients with pelvic recurrence from rectal and colon cancer the best potential for survival. The presence of hydronephrosis probably indicates a lower chance for complete surgical resection of the recurrence, but local control and improved survival may still be achieved, and about two thirds of patients may benefit from the operation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972173     DOI: 10.1016/j.amjsurg.2004.07.043

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Treatment efficacy and prognosis analysis in locally advanced or metastatic colorectal cancer patients with hydronephrosis.

Authors:  Gangling Tong; Boran Chen; Mingying Zhang; Tianyu Wang; Xuan Wu; Yuye Yan; Shubin Wang; Shuluan Li
Journal:  Mol Clin Oncol       Date:  2022-04-20

2.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

3.  Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer.

Authors:  Joo Ho Lee; Dae Yong Kim; Sun Young Kim; Ji Won Park; Hyo Seong Choi; Jae Hwan Oh; Hee Jin Chang; Tae Hyun Kim; Suk Won Park
Journal:  Radiat Oncol       Date:  2011-05-20       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.